Clinical Trial Update: Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF) [Phase 1]

View source ↗

Summary

Phase 1/IIa clinical trial evaluating injections of human umbilical cord-derived mesenchymal stem cells for idiopathic pulmonary fibrosis was completed at Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shanghai Life Science & Technology | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED